Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dulaglutide provides protection against sepsis-induced lung injury in mice by inhibiting inflammation and apoptosis
Yue Wang, Fengyi Deng, Zhong Xing, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175730-175730
Closed Access | Times Cited: 11

Showing 11 citing articles:

Protective effect and mechanism of Sufentanil on acute lung injury in septic mice
Hongqiao Hou, Bowen Jiang, Aiqing Zhu, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential
Weixuan Fan, Qiulei Zhang, Cong Wang, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114390-114390
Open Access
Liraglutide pretreatment attenuates sepsis-induced acute lung injury
Brandon Baer, Nathan D. Putz, Kyle Riedmann, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 325, Iss. 3, pp. L368-L384
Open Access | Times Cited: 11
Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
Fengyi Deng, Wenyan Wu, Xingyu Fan, et al.
International Journal of Endocrinology (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 11
The possible effect of anti-diabetic agents GLP-1RA and SGLT-2i on the respiratory system function
Kanella Kantreva, Paraskevi Κatsaounou, Katerina Saltiki, et al.
Endocrine (2024)
Closed Access | Times Cited: 3
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, et al.
Gut (2024), pp. gutjnl-334023
Closed Access | Times Cited: 2
The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects
Liyue Cao, Huijuan Song, Sheng Zhou, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112221-112221
Closed Access | Times Cited: 1
A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated Comorbidities
Faryal Haider, Syed Sarim Imam, Orien L. Tulp, et al.
(2024)
Open Access | Times Cited: 1
Impact of intestinal microenvironments in obesity and bariatric surgery on shaping macrophages
Michael Leyderman, Joel R. Wilmore, Timothy Shope, et al.
Immunometabolism (2023) Vol. 5, Iss. 4, pp. e00033-e00033
Open Access | Times Cited: 2
The Stat3 Inhibitor B9 Alleviates Lipopolysaccharide-Induced Acute Lung Injury Through its Anti-Inflammatory Effects
Min Mei Huang, Kai Lv, Liyue Cao, et al.
(2024)
Closed Access
Formononetin protects against sepsis-induced lung injury by directly inhibiting receptor for advanced glycation end products signaling pathway
Guoyong Zhang, Xin Han, Honglin Xu, et al.
Research Square (Research Square) (2024)
Open Access
Research Progress on Peptide Drugs for Type 2 Diabetes and the Possibility of Oral Administration
Xinxin Yang, Ruiting Lin, C Feng, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1353-1353
Open Access
Page 1

Scroll to top